Navigation Links
Autism Society of America Hosts Day on the Hill
Date:3/4/2008

Advocates Converge on Washington, D.C. from Across the Country to Make Their Voices Heard

BETHESDA, Md., March 4 /PRNewswire-USNewswire/ -- The Autism Society of America will host its 2008 Day on Capital Hill on March 12 and 13 to increase awareness and understanding of autism issues among federal policymakers. The political spectrum in the United States today directly impacts the autism spectrum, and families affected by autism must be heard in Washington and beyond. A group of passionate autism advocates will be working in our nation's capital during this event, calling on legislators to support legislative priorities, including:

-- Expanding the Promise to Individuals with Autism Act

-- Combating Autism Act Appropriations

-- Educational Issues (IDEA and No Child Left Behind)

-- Insurance coverage for autism spectrum disorders

-- Medicaid

-- Rehabilitation Act

-- Developmental Disabilities and Bill of Right and Assistance Act

-- Disability Savings Accounts

"One of the mainstays of ASA is our commitment to advocacy," said President and CEO Lee Grossman. "There is a critical need for increasing and improving services for individuals with autism across the lifespan. An event like Day on the Hill gives autism advocates across the country an opportunity to come to D.C. and address these important issues."

Day on the Hill also coincides with the second meeting of the re-formed Interagency Autism Coordinating Committee (IACC) on March 14. ASA is encouraging all attendees to attend this public meeting, in the hopes of encouraging the committee to explore more applied and treatment-based research. IACC was originally established by the Children's Health Act of 2000, and was re-authorized by the Combating Autism Act of 2006 to coordinate federal research on autism spectrum disorders. Grossman and ASA board member Stephen Shore are both members of the committee.

For more information or to schedule an interview, please contact Carin Yavorcik at 310-657-0881 x115 or cyavorcik@autism-society.org.

About Autism

Autism is a complex developmental disability that typically appears during the first three years of life and affects a person's ability to communicate and interact with others. Autism is defined by a certain set of behaviors and is a "spectrum disorder" that affects individuals differently and to varying degrees. There is no known single cause for autism, but increased awareness and funding can help families today.

About ASA:

ASA, the nation's leading grassroots autism organization, exists to improve the lives of all affected by autism. We do this by increasing public awareness about the day-to-day issues faced by people on the spectrum, advocating for appropriate services for individuals across the lifespan, and providing the latest information regarding treatment, education, research and advocacy. For more information, visit http://www.autism-society.org.


'/>"/>
SOURCE Autism Society of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. TV Personality and Best-Selling Author Jenny McCarthy Comes to Detroit to Share Her Story of the Struggles and Triumphs of Raising Her Son, Evan, During a Day-Long Autism Workshop
2. Pump It Up and Autism Society of America Launch Bounce for Autism
3. Financial struggles plague families of children with autism
4. Children with autism may learn from virtual peers
5. Government Concludes Vaccines Caused Autism
6. ToysRUs Kicks Off Fundraising Campaign to Benefit Autism Speaks
7. Citi-Mobile Teams Up With National Autism Association to Raise Autism Awareness
8. Autisms origins: Mothers antibody production may affect fetal brain
9. Wyeth Wins Thimerosal-Autism Case in Maryland Court
10. Pennsylvania Department of Public Welfare Announces Grant Opportunity for Regional Autism Centers
11. Autism Consultant Valerie Herskowitz Retains NewsMark Public Relations to Herald the Autism Support Village and Launch of www.valerieherskowitz.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology: